Patents by Inventor Sang-Kyung Shin

Sang-Kyung Shin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION, FOR PREVENTION OR TREATMENT OF CANCER DISEASE, COMPRISING CYTOTOXIC T CELLS ACTIVATED BY T HELPER CELL-DERIVED EXTRACELLULAR VESICLES AS ACTIVE INGREDIENT
    Publication number: 20240091355
    Abstract: The present invention relates to a composition, for prevention or treatment of cancer diseases, comprising CD8+ T cells activated by CD4+ T cell-derived extracellular vesicles as an active ingredient. It was found that the secretion of extracellular vesicles from cytokine-activated CD4+ T cells increases and the extracellular vesicles enhance proliferation and activity of CD8+ T cells to induce the death of cancer cells, thereby augmenting an anticancer effect. Thus, the present invention provides the CD8+ T cells activated by CD4+ T cell-derived extracellular vesicles as a pharmaceutical agent or an immunotherapeutic agent for cancer diseases, and a method for activating CD8+ T cells by using CD4+ T cell-derived extracellular vesicles to prepare CD8+ T cells showing excellent anticancer activity as described above.
    Type: Application
    Filed: September 18, 2020
    Publication date: March 21, 2024
    Applicants: KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Moon-Chang BAEK, Kyungmoo YEA, Do Kyung JUNG, Suyeon RYU, Sang Hee SHIN, In Seong JUNG
  • Semiconductor device
    Patent number: 10090058
    Abstract: A semiconductor device may be provided. The semiconductor device may be configured for detecting a defect of a fuse set. The semiconductor device may include a pseudo initial signal generator configured to generate pseudo initial information on the basis of a test mode signal. The semiconductor device may include a fuse-set defect detector configured to compare fuse-set information of a fuse set or the pseudo initial information with a reference value on the basis of a fuse-set address, and detect a defect of the fuse set.
    Type: Grant
    Filed: March 6, 2017
    Date of Patent: October 2, 2018
    Assignee: SK hynix Inc.
    Inventors: Sung Soo Chi, Dong Woo Lyu, Jin Yo Park, Sang Kyung Shin, Kwang Soo Ahn, Sung Su Cha
  • SEMICONDUCTOR DEVICE
    Publication number: 20180082754
    Abstract: A semiconductor device may be provided. The semiconductor device may be configured for detecting a defect of a fuse set. The semiconductor device may include a pseudo initial signal generator configured to generate pseudo initial information on the basis of a test mode signal. The semiconductor device may include a fuse-set defect detector configured to compare fuse-set information of a fuse set or the pseudo initial information with a reference value on the basis of a fuse-set address, and detect a defect of the fuse set.
    Type: Application
    Filed: March 6, 2017
    Publication date: March 22, 2018
    Applicant: SK hynix Inc.
    Inventors: Sung Soo CHI, Dong Woo LYU, Jin Yo PARK, Sang Kyung SHIN, Kwang Soo AHN, Sung Su CHA
  • Composition for promoting hematogenesis containing quercetin 3-O-?-(2?-galloyl)-rhamnopyranoside as active ingredient
    Patent number: 9289444
    Abstract: This invention relates to a composition for promoting hematopoiesis and for treating, preventing or alleviating cytopenia or bone marrow failure comprising quercetin 3-O-?-(2?-galloyl)-rhamnopyranoside (QGR) as active ingredient.
    Type: Grant
    Filed: January 9, 2012
    Date of Patent: March 22, 2016
    Assignee: Chungbuk National University Industry Academic Cooperation Foundation
    Inventors: Byeong Woo Ahn, Young Soo Kim, Heon Sang Jeong, Sang-Kyung Shin, Tae-Wang Kim, So-Young Youm
  • COMPOSITION FOR PROMOTING HEMATOGENESIS CONTAINING QUERCETIN 3-O-beta-(2''-GALLOYL)-RHAMNOPYRANOSIDE AS ACTIVE INGREDIENT
    Publication number: 20130345158
    Abstract: This invention relates to a composition for promoting hematopoiesis and for treating, preventing or alleviating cytopenia or bone marrow failure comprising quercetin 3-O-?-(2?-galloyl)-rhamnopyranoside (QGR) as active ingredient.
    Type: Application
    Filed: January 9, 2012
    Publication date: December 26, 2013
    Applicant: Chungbuk National University Industry Academic Corporation Foundation
    Inventors: Byeong Woo Ahn, Young Soo Kim, Heon Sang Jeong, Sang-Kyung Shin, Tae-Wang Kim, So-Young Youm